B Cell/Leukemia Panel Workshop: Summary and Comments

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4612-4848-4_1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

  1984cited by this paper
• Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

  1984cited by this paper
• Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow.

  1984cited by this paper
• B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

  1984cited by this paper
• Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.

  1984cited by this paper
• B Cells and Kidneys: A “B + CALLA” Workshop Analysis

  1984cited by this paper
• Human B Cell and B Cell Blast-Associated Surface Molecules Defined with Monoclonal Antibodies

  1984cited by this paper
• Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

  1984cited by this paper
• The Human B Cell Lineage Studied with Monoclonal Antibodies

  1984cited by this paper
• Human B Cell-Associated Antigens: Expression on Normal and Malignant B Lymphocytes

  1984cited by this paper
• Antigens on human plasma cells identified by monoclonal antibodies.

  1983cited by this paper
• Further Biochemical Studies of the Human B-Cell Differentiation Antigens B1 and B2

  1983cited by this paper
• Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA)

  1983cited by this paper
• B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

  1983cited by this paper
• Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody

  1983cited by this paper
• Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.

  1982cited by this paper
• B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

  1982cited by this paper
• A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

  1981cited by this paper
• Expression of a 26,000-dalton glycoprotein on activated human T cells.

  1981cited by this paper
• Expression of cell surface markers after human B lymphocyte activation.

  1981cited by this paper
• A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

  1981cited by this paper
• Characterization of a human B cell-specific antigen (B2) distinct from B1.

  1981cited by this paper
• A monoclonal antibody to human acute lymphoblastic leukaemia antigen

  1980cited by this paper
• Characterization of a human B lymphocyte-specific antigen.

  1980cited by this paper

• Treating adults with acute lymphoblastic leukemia: it is time to grow up

  2013cites this paper
• B-cell ontogeny depleted bone marrow transplantation: a recapitulation of normal B-cell differentiation following autologous, conventional, or T-cell

  2011cites this paper
• Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

  2008cites this paper
• Specification Sheet

  2008cites this paper
• Acute Myeloid a Distinct Biologic and Clinical Entity

  2005cites this paper
• Monoclonal Antibody I F5 (Anti-CD2O) Serotherapy of Human B Cell Lymphomas

  2005cites this paper
• Studies on Expression and Function of CD 19 Surface Determinant by Using B 43 Monoclonal Antibody and the Clinical Potential of Anti-CD 19 Immunotoxins

  2005cites this paper
• Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin

  2005cites this paper
• Towards the phenotyping of soft tissue tumours by cell surface molecules

  2005cites this paper
• Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies.

  2004cites this paper
• Mouse Ly-31.1 is an alloantigenic determinant of alkaline phosphatase predominantly expressed in the kidney and bone

  2004cites this paper
• Immunohistological demonstration of lymphocyte surface antigens in postmortem lymphoid tissues

  2004cites this paper
• Lymphoid malignancies: immunophenotypic analysis.

  2003cites this paper
• Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

  2003cites this paper
• Antibodies recognizing CD24 LAP epitope on human T cells enhance CD28 and IL‐2 T cell proliferation

  2001cites this paper
• Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro

  2000cites this paper
• Monoclonal antibodies putatively identifying porcine B cells.

  1998cites this paper
• Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia

  1998cites this paper
• Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.

  1998cites this paper
• Undifferentiated rhabdomyosarcoma with lymphoid phenotype expression.

  1997cites this paper
• Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders

  1995cites this paper
• Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses

  1995cites this paper
• Monoclonal antibodies identifying feline haemopoietic cell lineages

  1994cites this paper
• The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin‐7

  1994cites this paper
• Establishment of a human pro‐B cell line (JKB‐1) and its differentiation of preestablished bone marrow stromal cell layer

  1994cites this paper
• Antibodies to the protein core of the small cell lung cancer workshop antigen cluster‐w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine‐alanine‐proline

  1993cites this paper
• Biology of the neoplastic lymphocyte in B-CLL.

  1993cites this paper
• Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.

  1992influential citation
• Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A

  1992cites this paper
• Childhood Acute Lymphoblastic Leukemia Immunophenotypes and their Significance : Experience of the in 389 Children Immunophenotypes and their Significance : Experience of the in 389 Children Prognostic IGCI-Study

  1992cites this paper
• Childhood Acute Lymphoblastic Leukemia Immunophenotypes and their Prognostic Significance: Experience of the IGCI-Study in 389 Children

  1992cites this paper
• Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.

  1991cites this paper
• TRANSLOCATION (11:14)(q13:q32) WITHOUT REARRANGEMENT OF BCL1 ONCOGENE IN A CASE OF CHRONIC MYELOPROLIFERATIVE SYNDROME

  1991cites this paper
• B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL.

  1991cites this paper
• Preparation and characterization of a chimeric CD 19 monoclonal antibody

  1991cites this paper
• Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors.

  1991cites this paper
• Monoclonal antibodies VTB‐E3, IB5 and HB9 to the leucocyte/epithelial antigen CD24 resemble BA‐1 in recognizing sialic acid‐dependent epitope(s). Evidence that VIB‐E3 recognizes NeuAcα2‐6GalNAc and NeuAcα2‐6Gal sequences

  1991cites this paper
• TRISOMY 4 ASSOCIATED WITH ACUTE LYMPHOCYTIC LEUKAEMIA

  1991cites this paper
• Regulation of human B-cell activation and adhesion.

  1991cites this paper
• The relationship of chronic lymphocytic leukemia to normal activated B cells.

  1990cites this paper
• B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny.

  1990cites this paper
• Monoclonal antibody BA‐1 to the human B lymphocyte marker CD24 recognizes a sialic acid (N‐acetylneuraminic acid) dependent epitope in multi‐valent display on peptide

  1990cites this paper
• Regulation of human B-cell ontogeny.

  1990cites this paper
• Spectrum of Reactivity with Three Monoclonal Antibodies-MHM6(CD23), L30(CD24) and UCHB1-in B-Cell Leukaemias.

  1990cites this paper
• The Splenic White Pulp in Chronic Lymphocytic Leukaemia: A Microenvironment Associated with CR2 (CD21) Expression, Cell Transformation and Proliferation.

  1990cites this paper
• The plasmacytoid T cell or plasmacytoid monocyte--a sessile lymphoid cell with unique immunophenotype and unknown function, still awaiting lineage affiliation.

  1990cites this paper
• Characterization of a bovine leucocyte differentiation antigen of 145,000 MW restricted to B lymphocytes.

  1990influential citation
• Human B cells: differentiation and neoplasia.

  1990cites this paper
• Interleukin 4 and interferons α and γ regulate FcϵR2/CD23 mRNA expression on normal human B cells

  1990cites this paper
• Chronic-type B-Iymphocytic Leukaemias

  1990cites this paper
• Immunophenotypic similarities of mediastinal clear‐cell lymphoma and sinusoidal (monocytoid) b cells

  1989influential citation
• Characterization of B cells in severe combined immunodeficiency disease.

  1989cites this paper
• Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.

  1989influential citation
• Investigation of the CD10 (cALLA) negative acute lymphoblastic leukaemia: further description of a group with a poor prognosis

  1989cites this paper
• Clonal cell surface structures related to differentiation, activation and homing in B‐cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance

  1989cites this paper
• Immunologic characterization of lymphocytic leukemias. Methodologic and immunophenotypic considerations.

  1989cites this paper
• Isolated human follicular dendritic cells display a unique antigenic phenotype

  1989cites this paper
• Is there a direct differentiation‐inducing effect of human recombinant interferon on hairy cell leukemia in vitro?

  1989cites this paper
• B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.

  1989cites this paper
• Pediatric tumor markers.

  1989cites this paper
• Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodkin's lymphoma

  1989cites this paper
• Development of A Series of Monoclonal Antibodies Recognizing Leukocyte Differentiation Antigens of Japanese Monkeys (Macaca fuscata)

  1989cites this paper
• Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

  1988cites this paper
• Phenotypic characterization of immature lymphoid cells in human umbilical cord blood

  1988cites this paper
• B lymphocyte activation and differentiation

  1988cites this paper
• Immunological typing of acute leukemias: Immunoenzymatic staining of fixed cells compared with immunofluorescence staining of unfixed cells in suspension

  1988cites this paper
• Detailed Studies on Expression and Function of CD19 Surface Determinant by Using B43 Monoclonal Antibody and the Clinical Potential of Anti-CD19 Immunotoxins

  1988cites this paper
• Phenotypic heterogeneity of B‐ and T‐cell differentiation antigens in B‐CLL

  1988cites this paper
• B Prolymphocytic Leukemia Cell Lines: Phenotype and Response to B Cell Differentiation Factor

  1988cites this paper
• Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes

  1988cites this paper
• Molecular Biology of Interleukin 4 and Interleukin 5 Genes and Biology of their Products that Stimulate B Cells, T Cells and Hemopoietic Cells

  1988cites this paper
• Thymic medullary cells expressing B lymphocyte antigens.

  1988cites this paper
• Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.

  1988cites this paper
• Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.

  1988cites this paper
• Lack of vimentin occurring during the intrafollicular stages of B cell development characterizes follicular center cell lymphomas.

  1988cites this paper
• Immunologic approaches to the classification of lymphomas and lymphoid leukemias.

  1988cites this paper
• Intra- and extrathymic B cells in physiologic and pathologic conditions

  1988cites this paper
• Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3)(p36;q21) karyotype.

  1988cites this paper
• Centroblastic lymphoma of the thyroid supervening long-lasting chronic lymphocytic leukemia (B-CLL) demonstration of biclonality by Immunohistochemical and gene rearrangement analysis

  1988cites this paper
• Perspectives in Treatment of Adult Leukemia with High Dose Cytoreductive Therapy and Autologous Bone Marrow Treated Ex Vivo

  1988cites this paper
• CDw40 and BLCa‐specific monoclonal antibodies detect two distinct molecules which transmit progression signals to human B lymphocytes

  1988cites this paper
• CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset.

  1988cites this paper
• Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.

  1988cites this paper
• A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).

  1988cites this paper
• Mollaret's meningitis: CSF-immunocytological examinations

  1987cites this paper
• High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase

  1987cites this paper
• Immunologic classification of lymphoma and lymphoid leukemia.

  1987cites this paper
• Lymphocyte surface marker studies in the diagnosis of unexplained lymphocytosis.

  1987cites this paper
• Relationship between T200 antigen expression and stages of B cell differentiation in resurgent hyperplasia of bone marrow.

  1987cites this paper
• Defective expression of MHC class I antigens is frequent in B‐cell lymphomas of high‐grade malignancy

  1987cites this paper
• HUMAN LEUKOCYTE ANTIGENS: AN UPDATE ON STRUCTURE, FUNCTION AND NOMENCLATURE

  1987cites this paper
• Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry.

  1987cites this paper
• Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas.

  1987cites this paper
• Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.

  1987cites this paper
• Practical application of monoclonal antibodies to the diagnosis and classification of acute leukaemias.

  1987cites this paper
• Surface antigens associated with human B cell activation

  1986cites this paper
• Selective Killing of Normal and Neoplastic Human B Cells with Anti-CD 19- and Anti-CD22-Ricin A Chain Immunotoxins

  1986cites this paper